scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1054514149 |
P356 | DOI | 10.1007/S002620050178 |
10.1007/BF01519630 | ||
P953 | full work available at URL | https://europepmc.org/articles/PMC11037588 |
https://europepmc.org/articles/PMC11037588?pdf=render | ||
https://doi.org/10.1007/bf01519630 | ||
http://link.springer.com/article/10.1007/BF01519630/fulltext.html | ||
http://link.springer.com/content/pdf/10.1007/BF01519630.pdf | ||
http://link.springer.com/content/pdf/10.1007/BF01519630 | ||
P932 | PMC publication ID | 11037588 |
P698 | PubMed publication ID | 7600562 |
P50 | author | Ljubica Suturkova | Q71844217 |
P2093 | author name string | N. Latov | |
C. Briani | |||
I. Wirguin | |||
P2860 | cites work | Colorimetric Method for Determination of Sugars and Related Substances | Q26778459 |
Immunotherapeutic alternatives in superficial bladder cancer. Interferon, interleukin-2, and keyhole-limpet hemocyanin | Q35328643 | ||
Schistosoma mansoni shares a protective carbohydrate epitope with keyhole limpet hemocyanin | Q36352492 | ||
Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies | Q38326003 | ||
Gangliosides: structure, isolation, and analysis | Q40334634 | ||
T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo | Q41251096 | ||
Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. | Q41728009 | ||
Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression | Q67718083 | ||
Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier | Q67818505 | ||
Active Immunization of Human Ovarian Cancer Patients Against a Common Carcinoma (Thomsen-Friedenreich) Determinant Using a Synthetic Carbohydrate Antigen | Q68145704 | ||
Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice | Q68201747 | ||
The spectrum of neurologic disease associated with anti-GM1 antibodies | Q68464279 | ||
Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation | Q69382046 | ||
Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant | Q70577158 | ||
T and Tn, general carcinoma autoantigens | Q71372455 | ||
GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines | Q72657623 | ||
Specific interaction of peanut agglutinin with the glycolipid asialo GM1 | Q72667683 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 307-310 | |
P577 | publication date | 1995-05-01 | |
P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
P1476 | title | Keyhole limpet hemocyanin contains Gal(beta 1-3)-GalNAc determinants that are cross-reactive with the T antigen | |
Keyhole limpet hemocyanin contains Gal(β1–3)-GalNAc determinants that are cross-reactive with the T antigen | |||
P478 | volume | 40 |
Q31024258 | A novel Gal(beta1-4)Gal(beta1-4)Fuc(alpha1-6)-core modification attached to the proximal N-acetylglucosamine of keyhole limpet haemocyanin (KLH) N-glycans |
Q37510792 | A novel immunomodulatory hemocyanin from the limpet Fissurella latimarginata promotes potent anti-tumor activity in melanoma |
Q36442488 | A novel synthetic bipartite carrier protein for developing glycotope-based vaccines |
Q26700154 | Abalone Hemocyanin Blocks the Entry of Herpes Simplex Virus 1 into Cells: a Potential New Antiviral Strategy |
Q34184980 | Anti-cancer properties of gastropodan hemocyanins in murine model of colon carcinoma |
Q40975795 | Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM). |
Q36278684 | Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray |
Q26748686 | Exploring the ocean for new drug developments: Marine pharmacology |
Q35220367 | Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases |
Q33928761 | Glycan structures of the structural subunit (HtH1) of Haliotis tuberculata hemocyanin |
Q27302298 | Hemocyanins Stimulate Innate Immunity by Inducing Different Temporal Patterns of Proinflammatory Cytokine Expression in Macrophages |
Q64231109 | Immunotherapeutic Potential of Mollusk Hemocyanins in Combination with Human Vaccine Adjuvants in Murine Models of Oral Cancer |
Q37641011 | In vitro effect of molluscan hemocyanins on CAL-29 and T-24 bladder cancer cell lines |
Q37662531 | Molluskan Hemocyanins Activate the Classical Pathway of the Human Complement System through Natural Antibodies |
Q37181988 | Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathy |
Q64986582 | TLR4, but Neither Dectin-1 nor Dectin-2, Participates in the Mollusk Hemocyanin-Induced Proinflammatory Effects in Antigen-Presenting Cells From Mammals. |
Q37782118 | Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain–Barré syndrome? |